• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎儿生长受限:机制、流行病学及管理

Fetal Growth Restriction: Mechanisms, Epidemiology, and Management.

作者信息

Kamphof Hester D, Posthuma Selina, Gordijn Sanne J, Ganzevoort Wessel

机构信息

Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.

Department of Obstetrics & Gynecology, Amsterdam UMC, University of Amsterdam, 1100 DD Amsterdam, The Netherlands.

出版信息

Matern Fetal Med. 2022 Jul 22;4(3):186-196. doi: 10.1097/FM9.0000000000000161. eCollection 2022 Jul.

DOI:10.1097/FM9.0000000000000161
PMID:40406022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12094350/
Abstract

Fetal growth restriction (FGR) is the condition in which a fetus does not reach its intrinsic growth potential and in which the short-term and long-term risks of severe complications are increased. FGR is a frequent complication of pregnancy with a complex etiology and limited management options, other than timely delivery. The most common pathophysiological mechanism is placental insufficiency, due to many underlying causes such as maternal vascular malperfusion, fetal vascular malperfusion and villitis. Identifying truly growth restricted fetuses remains challenging. To date, FGR is often defined by a cut-off of the estimated fetal weight below a certain percentile on a population-based standard. However, small fetal size as a single marker does not discriminate adequately between fetuses or newborns that are constitutionally small but healthy and fetuses or newborns that are growth restricted and thus at risk for adverse outcomes. In 2016, the consensus definition of FGR was internationally accepted to better pinpoint the FGR population. In this review we will discuss the contemporary diagnosis and management issues. Different diagnostic markers are considered, like Doppler measurements, estimated fetal growth, interval growth, fetal movements, biomarkers, and placental markers.

摘要

胎儿生长受限(FGR)是指胎儿未达到其内在生长潜力且严重并发症的短期和长期风险增加的情况。FGR是一种常见的妊娠并发症,病因复杂,除了适时分娩外,治疗选择有限。最常见的病理生理机制是胎盘功能不全,其由许多潜在原因引起,如母体血管灌注不良、胎儿血管灌注不良和绒毛炎。识别真正生长受限的胎儿仍然具有挑战性。迄今为止,FGR通常根据基于人群标准的估计胎儿体重低于特定百分位数来定义。然而,仅以胎儿体型小作为单一指标,无法充分区分体质瘦小但健康的胎儿或新生儿与生长受限因而有不良结局风险的胎儿或新生儿。2016年,FGR的共识定义在国际上被接受,以更好地确定FGR人群。在本综述中,我们将讨论当代的诊断和管理问题。我们会考虑不同的诊断标志物,如多普勒测量、估计胎儿生长、生长间隔、胎动、生物标志物和胎盘标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/391d/12094350/ddbccd164897/mfm-4-186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/391d/12094350/4787239c1d7b/mfm-4-186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/391d/12094350/ddbccd164897/mfm-4-186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/391d/12094350/4787239c1d7b/mfm-4-186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/391d/12094350/ddbccd164897/mfm-4-186-g002.jpg

相似文献

1
Fetal Growth Restriction: Mechanisms, Epidemiology, and Management.胎儿生长受限:机制、流行病学及管理
Matern Fetal Med. 2022 Jul 22;4(3):186-196. doi: 10.1097/FM9.0000000000000161. eCollection 2022 Jul.
2
Fetal Growth Restriction胎儿生长受限
3
Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.胎儿生长受限与宫内生长受限:法国妇产科医师学院临床实践指南
Eur J Obstet Gynecol Reprod Biol. 2015 Oct;193:10-8. doi: 10.1016/j.ejogrb.2015.06.021. Epub 2015 Jul 2.
4
The accuracy of Fetoplacental Doppler in distinguishing between growth restricted and constitutionally small fetuses.胎儿胎盘多普勒超声在鉴别生长受限胎儿和体质性小胎儿方面的准确性。
Placenta. 2022 Mar 24;120:40-48. doi: 10.1016/j.placenta.2022.02.007. Epub 2022 Feb 15.
5
More Maternal Vascular Malperfusion and Chorioamnionitis in Placentas After Expectant Management vs. Immediate Delivery in Fetal Growth Restriction at (Near) Term: A Further Analysis of the DIGITAT Trial.期待治疗与即刻分娩对(近)足月胎儿生长受限胎盘母体血管灌注不良及绒毛膜羊膜炎影响的比较:DIGITAT试验的进一步分析
Front Endocrinol (Lausanne). 2019 Apr 24;10:238. doi: 10.3389/fendo.2019.00238. eCollection 2019.
6
Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction.在胎盘功能障碍高危妊娠中,连续循环胎盘生长因子水平和子宫动脉多普勒血流波形对潜在胎盘疾病的诊断价值。
Am J Obstet Gynecol. 2022 Oct;227(4):618.e1-618.e16. doi: 10.1016/j.ajog.2022.05.043. Epub 2022 May 27.
7
Risk of adverse perinatal outcomes in pregnancies with "small" fetuses not meeting Delphi consensus criteria for fetal growth restriction.未达到胎儿生长受限德尔菲共识标准的“小”胎儿妊娠的围产期不良结局风险。
Am J Obstet Gynecol. 2023 Oct;229(4):447.e1-447.e13. doi: 10.1016/j.ajog.2023.04.037. Epub 2023 Apr 30.
8
Placental pathology lesions: International Society for Ultrasound in Obstetrics and Gynecology vs Society for Maternal-Fetal Medicine fetal growth restriction definitions.胎盘病理学病变:国际妇产科超声学会与母胎医学学会胎儿生长受限定义的比较。
Am J Obstet Gynecol MFM. 2024 Aug;6(8):101422. doi: 10.1016/j.ajogmf.2024.101422. Epub 2024 Jul 3.
9
Predictive value of fetal growth trajectory from 20 weeks of gestation onwards for severe adverse perinatal outcome in low-risk population: secondary analysis of IRIS study.从 20 孕周起的胎儿生长轨迹对低危人群严重不良围生期结局的预测价值:IRIS 研究的二次分析。
Ultrasound Obstet Gynecol. 2023 Dec;62(6):796-804. doi: 10.1002/uog.26250.
10
Maternal serum soluble fms-like tyrosine kinase-1-to-placental growth factor ratio distinguishes growth-restricted from non-growth-restricted small-for-gestational-age fetuses.母体血清可溶性fms样酪氨酸激酶-1与胎盘生长因子的比值可区分生长受限与非生长受限的小于胎龄儿。
AJOG Glob Rep. 2024 Jan 9;4(1):100302. doi: 10.1016/j.xagr.2023.100302. eCollection 2024 Feb.

引用本文的文献

1
First-trimester triglyceride-glucose index and birth weight: a retrospective cohort mediation analysis of preterm birth and gestational complications.孕早期甘油三酯-葡萄糖指数与出生体重:早产和妊娠并发症的回顾性队列中介分析
BMC Pregnancy Childbirth. 2025 Jul 16;25(1):765. doi: 10.1186/s12884-025-07885-6.

本文引用的文献

1
Chronic Villitis of unknown etiology (VUE): Obstetrical features, outcome and treatment.原因不明的慢性绒毛膜炎(VUE):产科特征、结局和治疗。
J Reprod Immunol. 2021 Nov;148:103438. doi: 10.1016/j.jri.2021.103438. Epub 2021 Oct 23.
2
Maternal and fetal vascular lesions of malperfusion in the placentas associated with fetal and neonatal death: results of a prospective observational study.与胎儿和新生儿死亡相关的胎盘灌注不良的母体和胎儿血管病变:一项前瞻性观察研究的结果。
Am J Obstet Gynecol. 2021 Dec;225(6):660.e1-660.e12. doi: 10.1016/j.ajog.2021.06.001. Epub 2021 Jun 8.
3
The CErebro Placental RAtio as indicator for delivery following perception of reduced fetal movements, protocol for an international cluster randomised clinical trial; the CEPRA study.
胎儿运动减少感知后行剖宫产的脑胎盘比值预测指标:一项国际多中心随机临床试验方案;CEPRA 研究。
BMC Pregnancy Childbirth. 2021 Apr 9;21(1):285. doi: 10.1186/s12884-021-03760-2.
4
FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.国际妇产科联盟(FIGO)胎儿生长倡议:胎儿生长受限筛查、诊断及管理的最佳实践建议
Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1(Suppl 1):3-57. doi: 10.1002/ijgo.13522.
5
Fetal vascular malperfusion (FVM): diagnostic implications and clinical associations.胎儿血管灌注异常(FVM):诊断意义和临床关联。
J Matern Fetal Neonatal Med. 2022 Dec;35(23):4526-4533. doi: 10.1080/14767058.2020.1854215. Epub 2020 Dec 1.
6
Prevention of preeclampsia with aspirin.阿司匹林预防子痫前期
Am J Obstet Gynecol. 2022 Feb;226(2S):S1108-S1119. doi: 10.1016/j.ajog.2020.08.045. Epub 2020 Aug 21.
7
ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction.国际妇产科超声学会(ISUOG)实践指南:小于胎龄儿和胎儿生长受限的诊断与管理
Ultrasound Obstet Gynecol. 2020 Aug;56(2):298-312. doi: 10.1002/uog.22134.
8
Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial.母体西地那非与安慰剂治疗严重早发型胎儿生长受限孕妇的随机临床试验。
JAMA Netw Open. 2020 Jun 1;3(6):e205323. doi: 10.1001/jamanetworkopen.2020.5323.
9
A maternal serum metabolite ratio predicts fetal growth restriction at term.母体血清代谢物比值可预测足月胎儿生长受限。
Nat Med. 2020 Mar;26(3):348-353. doi: 10.1038/s41591-020-0804-9. Epub 2020 Mar 11.
10
Antiplatelet agents for preventing pre-eclampsia and its complications.用于预防子痫前期及其并发症的抗血小板药物。
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD004659. doi: 10.1002/14651858.CD004659.pub3.